Davern Capital Partners, LP Q4 2025 Filing
Filed February 13, 2026
Portfolio Value
$309.3M
Holdings
14
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (14 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | PFEPFIZER INC | 2,042,242 | $50.9M | 16.44% | |
| 2 | REGNREGENERON PHARMACEUTICALS | 52,420 | $40.5M | 13.08% | |
| 3 | BNTXBIONTECH SE | 371,216 | $35.3M | 11.43% | |
| 4 | RPRXROYALTY PHARMA PLC | 840,650 | $32.5M | 10.50% | |
| 5 | ARGXARGENX SE | 35,685 | $30.0M | 9.70% | |
| 6 | LEGNLEGEND BIOTECH CORP | 1,056,668 | $23.0M | 7.43% | |
| 7 | ROIVROIVANT SCIENCES LTD | 1,028,298 | $22.3M | 7.21% | |
| 8 | ISIIONIS PHARMACEUTICALS INC | 238,477 | $18.9M | 6.10% | |
| 9 | NTRANATERA INC | 78,650 | $18.0M | 5.83% | |
| 10 | LLYELI LILLY & CO | 8,307 | $8.9M | 2.89% | |
| 11 | VRDNVIRIDIAN THERAPEUTICS INC | 261,615 | $8.1M | 2.63% | |
| 12 | MLYSMINERALYS THERAPEUTICS INC | 210,648 | $7.6M | 2.47% | |
| 13 | CGONCG ONCOLOGY INC | 162,005 | $6.7M | 2.17% | |
| 14 | ABVXABIVAX SA | 48,502 | $6.5M | 2.11% |